← Eichor
Condition: Radiotracer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Radiotracer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique
Phase 2 · 1 location(s) · Emory University · NCT06865768Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease
NA · 1 location(s) · Nationwide Children's Hospital · NCT03622359Evaluation of the Pharmacokinetics, Biodistribution and Radiation Dosimetry of [18F]MODAG-009 Positron Emission Tomograp
EARLY_Phase 1 · 1 location(s) · MODAG GmbH · NCT07617688PET Imaging Study of 64Cu-GRIP B for Patients Receiving CD19-directed CAR-T Therapy
Phase 1 · 1 location(s) · Michael Randall · NCT06522932Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake
Phase 2 · 1 location(s) · Akiva Mintz · NCT07284589Multicenter Assessment of Clinical Utility PET / MR With the Use of the Radiotracer 68Ga-PSMA-11 in Therapy Planning Per
NA · 7 location(s) · Medical University of Bialystok · NCT05582876Evaluation of [18F]GATT-44 for Positron Emission Tomography Imaging of the GABA Transporter-1
EARLY_Phase 1 · 1 location(s) · Yale University · NCT0745773664Cu-GRIP B in Patients With Advanced Malignancies
Phase 1/Phase 2 · 1 location(s) · Rahul Aggarwal · NCT05888532Study of Neuroinflammation in Multiple Sclerosis by PET-MRI Imaging Using the Radiotracer ([18F]-DPA-714) : a Multicentr
NA · 7 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06280742DK222 Study at Hopkins
Phase 1 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT07140315Evaluation of an EpCAM-Targeted Radiotracer in Epithelial Tumors
NA · 1 location(s) · Peking University People's Hospital · NCT07400263Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis
Phase 2 · 1 location(s) · Baptist Health South Florida · NCT05554302Assessment of Early Post-operative Nuclear Imaging in Neurosurgery: a Safety and Feasibility Study in Patients Operated
NA · 1 location(s) · Beta Emitting Accurate Monitored Systems · NCT07274397Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT03604315Imaging Phosphodiesterase 4B (PDE4B) in People With Psychiatric Disorders With Positron Emission Tomography (PET) and th
Phase N/A · 1 location(s) · Yale University · NCT07488819TSPO-PET/MRI in Surveillance of Neuroinflammation in the Central Nervous System
Phase N/A · 1 location(s) · Tongji Hospital · NCT06467773FTT PET/CT in Pancreatic Neuroendocrine Tumors
Phase 1 · 1 location(s) · Abramson Cancer Center at Penn Medicine · NCT07114939Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Huma
EARLY_Phase 1 · 2 location(s) · Benjamin Viglianti · NCT04546126Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Huma
EARLY_Phase 1 · 1 location(s) · Benjamin Viglianti · NCT04532489Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head
Phase 1 · 1 location(s) · Vanderbilt-Ingram Cancer Center · NCT07217028Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.
Phase N/A · 1 location(s) · Massachusetts General Hospital · NCT06252493Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/
Phase 1 · 1 location(s) · Abramson Cancer Center at Penn Medicine · NCT02637934Fibrosis Associated Protein Inhibitor (FAPI) Radiotracer-based Imaging to Identify Fibrotic Intestinal Crohn's Disease
Phase N/A · 1 location(s) · University of Edinburgh · NCT07152431A Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With AS
Phase 2 · 2 location(s) · Cerus Corporation · NCT07015437
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.